All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-27338425
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 27338425 A71T
PR
gag-pol
HIV Infections
D
G
C
L
View
2 27338425 A71V
PR
gag-pol
HIV Infections
D
G
C
L
View
3 27338425 A98G
RT
gag-pol
HIV Infections
D
G
C
L
View
4 27338425 D67N
RT
gag-pol
HIV Infections
D
G
C
L
View
5 27338425 E138A
RT
gag-pol
HIV Infections
D
G
C
L
View
6 27338425 G73A
PR
gag-pol
HIV Infections
D
G
C
L
View
7 27338425 G73G
PR
gag-pol
HIV Infections
D
G
C
L
View
8 27338425 H221Y
RT
gag-pol
HIV Infections
D
G
C
L
View
9 27338425 I47A
PR
gag-pol
HIV Infections
D
G
C
L
View
10 27338425 I54I
PR
gag-pol
HIV Infections
D
G
C
L
View
11 27338425 I54V
PR
gag-pol
HIV Infections
D
G
C
L
View
12 27338425 K101P
RT
gag-pol
HIV Infections
D
G
C
L
View
13 27338425 K103N
RT
gag-pol
HIV Infections
D
G
C
L
View
14 27338425 K103S
RT
gag-pol
HIV Infections
D
G
C
L
View
15 27338425 K20T
PR
gag-pol
HIV Infections
D
G
C
L
View
16 27338425 K219N
RT
gag-pol
HIV Infections
D
G
C
L
View
17 27338425 K219Q
RT
gag-pol
HIV Infections
D
G
C
L
View
18 27338425 K219R
RT
gag-pol
HIV Infections
D
G
C
L
View
19 27338425 K70R
RT
gag-pol
HIV Infections
D
G
C
L
View
20 27338425 L10F
PR
gag-pol
HIV Infections
D
G
C
L
View
21 27338425 L10I
PR
gag-pol
HIV Infections
D
G
C
L
View
22 27338425 L10V
PR
gag-pol
HIV Infections
D
G
C
L
View
23 27338425 L210W
RT
gag-pol
HIV Infections
D
G
C
L
View
24 27338425 L33F
PR
gag-pol
HIV Infections
D
G
C
L
View
25 27338425 L76V
PR
gag-pol
HIV Infections
D
G
C
L
View
26 27338425 L90L
PR
gag-pol
HIV Infections
D
G
C
L
View
27 27338425 L90M
PR
gag-pol
HIV Infections
D
G
C
L
View
28 27338425 M184V
RT
gag-pol
HIV Infections
D
G
C
L
View
29 27338425 M41L
RT
gag-pol
HIV Infections
D
G
C
L
View
30 27338425 M46L
PR
gag-pol
HIV Infections
D
G
C
L
View
31 27338425 P225H
RT
gag-pol
HIV Infections
D
G
C
L
View
32 27338425 T215D
RT
gag-pol
HIV Infections
D
G
C
L
View
33 27338425 T215S
RT
gag-pol
HIV Infections
D
G
C
L
View
34 27338425 T215Y
RT
gag-pol
HIV Infections
D
G
C
L
View
35 27338425 T69D
RT
gag-pol
HIV Infections
D
G
C
L
View
36 27338425 T69N
RT
gag-pol
HIV Infections
D
G
C
L
View
37 27338425 V106I
RT
gag-pol
HIV Infections
D
G
C
L
View
38 27338425 V179D
RT
gag-pol
HIV Infections
D
G
C
L
View
39 27338425 V32I
PR
gag-pol
HIV Infections
D
G
C
L
View
40 27338425 V75M
RT
gag-pol
HIV Infections
D
G
C
L
View
41 27338425 V82A
PR
gag-pol
HIV Infections
D
G
C
L
View
42 27338425 V82V
PR
gag-pol
HIV Infections
D
G
C
L
View
43 27338425 V90I
RT
gag-pol
HIV Infections
D
G
C
L
View
44 27338425 Y181C
RT
gag-pol
HIV Infections
D
G
C
L
View
45 27338425 Y188H
RT
gag-pol
HIV Infections
D
G
C
L
View
46 27338425 Y188L
RT
gag-pol
HIV Infections
D
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.